KATHLEEN WOHLDMANN: Open Payments
NPI 1619484268 · WENTZVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 14 payments from 10 companies in 2025. Trend: 2023 $2,487 · 2024 $1,183 · 2025 $316
Food & beverage: $217Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $116 |
| Kestra Medical Technology Services, Inc. | 3 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| HEARTFLOW, INC. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: OPSUMIT, Assure WCD, Rybelsus, VYNDAQEL, QULIPTA, WAINUA, ELIQUIS, UPTRAVI.
Industry payments across MO — which companies pay providers there.
